missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CERILLIANT™ (+/-)-threo-Ritalinic acid-D10 Hydrochloride Solution, 1.0 mg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: Merck Emd Millipore R0271ML
Description
Ritalinic acid is the major urinary metabolite of methylphenidate, which is approved for treatment of ADHD (Attention-Deficit Hyperactivity Disorder) and narcolepsy. This new stable-labeled internal standard is suitable for a wide variety of GC/MS and LC/MS applications from clinical toxicology and urine drug testing to forensic analysis and isotope dilution methods.Spécifications
| 67-56-1 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| 265.80 | |
| 1 mL |
| C13H7D10NO2 · HCl | |
| 1.0 mg/mL in methanol (as free base) | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
CERILLIANT is a registered trademark of Cerilliant Corporation